8 Coupons
-
Special Offer
-
30% off
written reports, including local media accounts, professional medical papers and internal emails were also examined.
.
.
loading more comments
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .